Intravenous cangrelor vs oral ticagrelor in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention: A randomised controlled trial
Salahaddin Ubaid, Thomas J Ford, Colin Berry, Benjamin Wrigley, Mark Thomas, Heather Murray, J Vickers, Armesilla, Jon Townend, Saib Khogali, Shahzad Munir, Joe Martins, R Jaumdally, Elisa J McAlindon and James M Cotton
DOI: https://doi.org/10.7861/clinmedicine.19-2-s128
Clin Med March 2019 Salahaddin Ubaid
AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
Thomas J Ford
BGolden Jubilee National Hospital, Glasgow, UK
CBritish Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
Colin Berry
BGolden Jubilee National Hospital, Glasgow, UK
CBritish Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
Benjamin Wrigley
AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
Mark Thomas
DQueen Elizabeth Hospital, Birmingham, UK
Heather Murray
ERobertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
J Vickers
Armesilla
FUniversity of Wolverhampton, Wolverhampton, UK.
Jon Townend
DQueen Elizabeth Hospital, Birmingham, UK
Saib Khogali
AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
Shahzad Munir
AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
Joe Martins
AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
R Jaumdally
Elisa J McAlindon
AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
James M Cotton
AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
FUniversity of Wolverhampton, Wolverhampton, UK.
Article Information
vol. 19 no. Suppl 2 128
Published By:
Print ISSN:
Online ISSN:
History:
- Published online May 30, 2019.
Copyright & Usage:
© Royal College of Physicians 2019. All rights reserved.
Author Information
- Salahaddin UbaidA,
- Thomas J FordBC,
- Colin BerryBC,
- Benjamin WrigleyA,
- Mark ThomasD,
- Heather MurrayE,
- J Vickers,
- ArmesillaF,
- Jon TownendD,
- Saib KhogaliA,
- Shahzad MunirA,
- Joe MartinsA,
- R Jaumdally,
- Elisa J McAlindonA and
- James M CottonAF
- AHeart and Lung Centre, New Cross Hospital, Wolverhampton, UK
- BGolden Jubilee National Hospital, Glasgow, UK
- CBritish Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
- DQueen Elizabeth Hospital, Birmingham, UK
- ERobertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
- FUniversity of Wolverhampton, Wolverhampton, UK.
Article usage
Article Tools
Intravenous cangrelor vs oral ticagrelor in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention: A randomised controlled trial
Salahaddin Ubaid, Thomas J Ford, Colin Berry, Benjamin Wrigley, Mark Thomas, Heather Murray, J Vickers, Armesilla, Jon Townend, Saib Khogali, Shahzad Munir, Joe Martins, R Jaumdally, Elisa J McAlindon, James M Cotton
Clinical Medicine Mar 2019, 19 (Suppl 2) 128; DOI: 10.7861/clinmedicine.19-2-s128
Citation Manager Formats
Intravenous cangrelor vs oral ticagrelor in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention: A randomised controlled trial
Salahaddin Ubaid, Thomas J Ford, Colin Berry, Benjamin Wrigley, Mark Thomas, Heather Murray, J Vickers, Armesilla, Jon Townend, Saib Khogali, Shahzad Munir, Joe Martins, R Jaumdally, Elisa J McAlindon, James M Cotton
Clinical Medicine Mar 2019, 19 (Suppl 2) 128; DOI: 10.7861/clinmedicine.19-2-s128
Related Articles
- No related articles found.
Cited By...
- No citing articles found.